MMSI — Merit Medical Systems Cashflow Statement
0.000.00%
Last trade - 00:00
- $4.28bn
- $4.52bn
- $1.26bn
- 87
- 27
- 75
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5.45 | -9.84 | 48.5 | 74.5 | 94.4 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 48.4 | 58.1 | 37.2 | 44.3 | 43.4 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -55.7 | 34.2 | -17.8 | -71.4 | -70 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 77.8 | 165 | 147 | 114 | 145 |
Capital Expenditures | -81.5 | -49.3 | -30.8 | -45 | -36.7 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -53 | -9.38 | -6.39 | -12.4 | -139 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -134 | -58.7 | -37.2 | -57.4 | -175 |
Financing Cash Flow Items | -17.2 | -14 | -11.2 | -35.4 | -75.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 33.5 | -95.7 | -98.4 | -60.3 | 559 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -23 | 12.6 | 10.8 | -7.19 | 529 |